Related Articles

• Progression‑free survival of first‑line treatment with molecular‑targeted therapy may be a meaningful intermediate endpoint for overall survival in patients with metastatic renal cell carcinoma
• Cetuximab treatment for metastatic colorectal cancer with KRAS p.G13D mutations improves progression-free survival
• Vimentin expression is associated with decreased survival in gastric cancer
• First-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status
• An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer